Anixa Biosciences Inc (ANIX) stock
ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
$2.62−0.06 (-2.24%)
Close on Nov 13, 2026Market cap $91.08MP/E –Yield –
Anixa Biosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Anixa Biosciences's enterprise value was $81.01M on Nov 11, 2026, against $133.44M a year earlier. Over the last 5 years it ranged from $46.45M to $139.20M, with a median of $81.98M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $81.01M | -6.5% |
| 2025 | Dec 31, 2025 | $86.62M | +61.4% |
| 2024 | Dec 31, 2024 | $53.66M | -44.1% |
| 2023 | Dec 29, 2023 | $96.03M | -4.8% |
| 2022 | Dec 30, 2022 | $100.85M | +90.8% |
| 2021 | Dec 31, 2021 | $52.85M | -18.5% |
| 2020 | Dec 31, 2020 | $64.89M | +7.4% |
| 2019 | Dec 31, 2019 | $60.42M | -12.7% |
| 2018 | Dec 31, 2018 | $69.19M | +113.9% |
| 2017 | Dec 29, 2017 | $32.34M | -26.5% |
| 2016 | Dec 30, 2016 | $44.02M | +125.9% |
| 2015 | Dec 31, 2015 | $19.49M | +6.5% |
| 2014 | Dec 31, 2014 | $18.31M | -52.9% |
| 2013 | Dec 31, 2013 | $38.86M | +19.7% |
| 2012 | Dec 31, 2012 | $32.46M | +98.5% |
| 2011 | Dec 30, 2011 | $16.35M | -47.6% |
| 2010 | Dec 31, 2010 | $31.19M | – |
See a number that looks wrong?